FROM OUR EXPERTS
Part of the Bill of Rights, the 8th Amendment to the United States Constitution, guarantees that prisoners shall not be subjected to cruel and unusual punishment . This clause prohibits torture and has been widely cited in support of abolishing the death penalty. It also forbids the withholding of medical treatment from prisoners in need of treatment. A prisoner in need of medical care has nowhere to go but the prison authorities. To withhold treatment from a prisoner would be using the medical condition of the prisoner as a part of their punishment - and this is held to be cruel and unusual in a long line of 8th Amendment cases. Cases hold that the infliction of pain from an untreated medical condition, or indifference by prison authorities to the medical needs of the prisoner, is cruel and unusual punishment. The Federal Third Circuit Court of Appeals described the standard for 8th Amendment medical treatment cases in Iseley v. Beard . 1 First, the co...
Two weeks ago I told you that the FDA approved a generic version of Lyrica ® (pregabalin) made by Lupin Limited, but I wasn't able to find out when it might actually be available on the market. Now I know why I couldn't find that information. Apparently Lupin was awaiting a court decision as to whether or not on Pfizer Inc.'s patents for Lyrica were valid.
That decision came down last Thursday, July 19, 2012. Judge Gregory M. Sleet of the U.S. District Court of Delaware upheld the validity of Pfizer's patents for Lyrica, giving them exclusive rights to the medication until December 30, 2018. In addition, Judge Sleet ordered the FDA to stop approving generic forms of pregabalin until Pfizer's patents expire.
The Story Behind the Decision
In 2009, Pfizer filed a lawsuit charging patent infringement against Israel's Teva Pharmaceutical Industries, India's Sun Pharmaceutical Industries, and U.S. firms Mylan and Watson Pharmaceuticals, who all sought FDA approval ...
There is a lot of talk about research and medical advances
in the treatment of multiple sclerosis , but I would like to return to the fundamentals of MS
care and how these new treatment options fall into the framework of MS care.
There are three important arms of MS treatment:
Modifying Agents - Medications that are used to change the course of MS, but
which you may not feel any current effect from (though you may have side
effects unfortunately), but are like an insurance policy for the future. There
are 5 FDA approved medications for Relapsing forms of MS: Avonex ®, Rebif ®,
Betaseron ®, Copaxone ® and Tysabri ®. Novantrone® is a chemotherapy drug, also FDA
approved for worsening relapsing MS or secondary progressive MS.
Most of the research you read about
is aimed at disease modification: the oral medications (Cladribine, Fingolimod,
Teriflunomide, BG00012, Laquinomod, etc.); the newer injectables (Atacicept
etc.); the IV infusions ...
You should know
Answers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.